loader
(function(){let t=document.createElement("style");t.innerText=".booking-button{background-color:#003a43;color:white;position:fixed;bottom:1.25rem;left: 1rem;width:4.5rem;height:4.5rem;padding:1.25rem;display:flex;align-items:center;justify-content:center;border-radius:9999px;box-shadow:0 10px 15px -3px rgba(0,0,0,0.1),0 4px 6px -2px rgba(0,0,0,0.05);cursor:pointer;border:none}.booking-button:hover{background-color:#374151}.booking-button:focus{outline:none;outline:2px solid rgba(107,114,128,0.5)}",document.head.appendChild(t);let n=document.createElement("div");n.innerHTML='',document.body.appendChild(n),document.getElementById("bookingButton").addEventListener("click",function(){let e=document.getElementById("iframeContainer"),o=document.getElementById("bookingIframe");o.src="https://d2oe0ra32qx05a.cloudfront.net/?practiceKey=k_1_75732",e.style.display="block"}),document.getElementById("iframeContainer").addEventListener("click",function(e){if(e.target===this)this.style.display=""})})();

Medication-Assisted Treatment (MAT) and Controlled Substance Policy

Commitment to Safe, Evidence-Based Care Aegis Medical specializes in online Medication-Assisted Treatment (MAT) for opioid use disorder, utilizing buprenorphine/naloxone (Suboxone®) in combination with counseling and behavioral therapies. Because buprenorphine is a Schedule III controlled substance, its prescribing is highly regulated by federal and state agencies.

Aegis Medical is committed to providing compassionate, stigma-free care while strictly adhering to all Drug Enforcement Administration (DEA) and state medical board regulations to ensure patient safety and prevent medication diversion.

Telehealth & Prescribing Protocols To remain compliant and keep our patients safe, all individuals receiving MAT through Aegis Medical must agree to the following clinical protocols:

  • State Prescription Monitoring Programs (PDMP): By law, our medical providers must actively query your state’s prescription drug monitoring database prior to your initial prescription and before every refill. This ensures there are no unsafe medication interactions.
  • Routine Drug Screening: As a standard component of a compliant MAT program, patients may be required to participate in routine, random, or for-cause drug testing. This may be conducted via mailed oral swab kits, UDS or orders sent to a local laboratory facility.
  • Geographic Location Requirements: Telehealth laws require that patients be physically located in a state where their provider is actively licensed at the exact time of their virtual appointment.
  • Counseling & Behavioral Health: MAT is most effective when combined with behavioral therapy. Your provider will discuss ongoing counseling requirements as part of your comprehensive treatment plan.

Lost, Stolen, or Early Refill Policy Aegis Medical maintains a strict policy regarding the management of controlled substance prescriptions:

  • No Early Refills: Prescriptions will only be refilled on or after the scheduled due date. We do not authorize early refills.
  • Lost or Stolen Medications: Patients are responsible for the safe and secure storage of their medication. Aegis Medical generally does not replace lost, damaged, spilled, or stolen medications. In the rare event of theft, a formal police report may be required before a provider will even consider a replacement, which is entirely at the provider’s clinical discretion.
  • Pharmacy Changes: If you need to change your designated local pharmacy, you must notify our care team at least 48 hours prior to your next appointment or refill date.

Termination of Treatment Aegis Medical reserves the right to discharge a patient or transition them to a higher level of in-person care (such as a local detox center or inpatient rehab) if telehealth MAT is no longer deemed clinically appropriate or safe, or if the patient violates this controlled substance policy.

Aegis Medical is a symbolic shield for our patients, protecting them from harm and supporting them through their courageous journey to recovery.

Michigan  |  Ohio  |  Kentucky  | Indiana  |  Florida |  Arizona
Suboxone® is a registered trademark of Indivior UK Limited. Aegis Medical is not affiliated with Indivior UK Limited or its affiliates (“Indivior”), and any reference to it or its intellectual property is for informational purposes only and is not endorsed or sponsored by Indivior.

Disclaimer: The content provided on the Aegis Medical website is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Browsing this site or submitting a contact form does not establish a doctor-patient relationship. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or addiction treatment. If you are experiencing a medical emergency, a drug overdose, or a psychiatric crisis, please call 911 or go to your nearest emergency room immediately. You can also dial 988 for the Suicide & Crisis Lifeline.

© 2026 Aegis Medical. Website by BrandLume

Contact us

Name(Required)
MM slash DD slash YYYY
Please let us know what's on your mind. Have a question for us? Ask away.
SMS / TCPA Compliance Checkbox (Required if you text them)
Privacy & Emergency Acknowledgment Checkbox